z-logo
open-access-imgOpen Access
Managing long-term high-dose prescription opioids in patients with non-cancer pain: The potential role of sublingual buprenorphine
Author(s) -
Joan Chong,
Matthew Frei,
Dan I. Lubman
Publication year - 2020
Publication title -
australian journal of general practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 42
eISSN - 2208-794X
pISSN - 2208-7958
DOI - 10.31128/ajgp-07-19-4994
Subject(s) - buprenorphine , medicine , opioid , (+) naloxone , chronic pain , cancer pain , addiction , medical prescription , intensive care medicine , anesthesia , cancer , pharmacology , psychiatry , receptor
Opioids are frequently used to manage chronic non-cancer pain despite the lack of evidence of benefit and clear evidence of opioid-related harms. Patients undergoing high-dose opioid therapy are at risk of multiple complications, such as opioid toxicity, including fatal overdose and opioid dependence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here